Terra L. Lasho

Also affiliated with WinnMed, University of Minnesota Rochester, Mayo Clinic in Arizona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations”.

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

Blood(2024)10.1182/blood.2024024962

N/A

0.472DataRank · unranked

13 citations

Jenna Fernandez, Terra L. Lasho, Christy M. Finke, Michelle Amundson, Kristen McCullough +8 more

Phase II trial assessing safety and preliminary efficacy of high-dose intravenous ascorbic acid in patients with TET2-mutant clonal cytopenias of undetermined significance.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7076

N/A

0.208DataRank · unranked

3 citations

Terra L. Lasho, Jenna Fernandez, Christy M. Finke, Michelle Amundson, Betsy LaPlant +4 more

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

Nature Communications(2021)10.1038/s41467-021-23186-w

N/A

0DataRank · unranked

100 citations

Denis Vorobyev, Terra L. Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder +30 more

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1353

N/A

0DataRank · unranked

46 citations

Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Wen, Te Ling +20 more

Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia

Nature Communications(2022)10.1038/s41467-022-29142-6

N/A

0DataRank · unranked

31 citations

Ryan M. Carr, Terra L. Lasho, Christy M. Finke, Abhishek A. Mangaonkar, Christopher L. Pin +10 more

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood Cancer Journal(2022)10.1038/s41408-022-00622-8

N/A

0DataRank · unranked

20 citations

Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al‐Kali +10 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.21.504657

N/A

0DataRank · unranked

0 citations

Mei Yu, Adhithi Rajagopalan, Yun Zhou, Yubin Feng, Anthony J. Veltri +9 more

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.01.514753

N/A

0DataRank · unranked

0 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +19 more

Spectrum of clonal hematopoiesis in VEXAS syndrome

Blood(2023)10.1182/blood.2022018774

N/A

0DataRank · unranked

104 citations

Yael Kusne, Jenna Fernandez, Terra L. Lasho, Ruba Shalhoub, Xiaoyang Ma +31 more

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3929

N/A

0DataRank · unranked

5 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +20 more

Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses

Oncogene(2023)10.1038/s41388-023-02684-9

N/A

0DataRank · unranked

5 citations

Mei Yu, Govinda Poudel, Anthony J. Veltri, Yun Zhou, Adhithi Rajagopalan +10 more

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

Leukemia Research(2023)10.1016/j.leukres.2023.107340

N/A

0DataRank · unranked

2 citations

David M. Swoboda, Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard +4 more

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

American Journal of Hematology(2020)10.1002/ajh.25853

N/A

0DataRank · unranked

10 citations

Terra L. Lasho, Eric Padron, Kristen McCullough, Aref Al‐Kali, Ayalew Tefferi +6 more

Landscape and Clinicopathologic Features of RAS Pathway Mutations in Chronic Myelomonocytic Leukemia

Blood(2024)10.1182/blood-2024-208890

N/A

0DataRank · unranked

1 citations

Kelly S. Chien, Sanam Loghavi, Rashmi Kanagal‐Shamanna, Anuya Natu, Mark E. Gurney +22 more

Prevalence and significance of clonal hematopoiesis of indeterminate prognosis (CHIP) in multiple myeloma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8542

N/A

0DataRank · unranked

2 citations

Betsy LaPlant, Shaji Kumar, Kimbery Henderson, Angela Dispenzieri, Terra L. Lasho +3 more